LBA69 - Combination treatment with cobimetinib (C) and atezolizumab (A) vs pembrolizumab (P) in previously untreated patients (pts) with BRAFV600 wild type (wt) advanced melanoma: Primary analysis from the phase III IMspire170 trial
| Autor: | Arance, A.M. 1, Gogas, H. 2, Dreno, B. 3, Flaherty, K.T. 4, Demidov, L. 5, Stroyakovskiy, D. 6, Eroglu, Z. 7, Ferrucci, P.F. 8, Pigozzo, J. 9, Rutkowski, P. 10, Mackiewicz, J. 11, Rooney, I. 12, Voulgari, A. 13, Troutman, S. 12, Pitcher, B. 14, Yan, Y. 15, Larkin, J.M.G. 16 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v906-v906 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|